Jingtao Wu

Pharmacokinetics and Pharmacodynamics of Febuxostat, a New Non-purine Selective Inhibitor of Xanthine Oxidase in Subjects with Renal Impairment

Michael D. Mayer, Reza Khosravan, Laurent Vernillet et al. · American Journal of Therapeutics · 2005 · 153 citations

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Andrew L. Frelinger, Ronald Lee, Darcy J. Mulford et al. · Journal of the American College of Cardiology · 2012 · 147 citations

Pharmacological Study, Healthy Volunteers, Pharmacology +5

WAMS applications in Chinese power systems

Xiaorong Xie, Yaozhong Xin, Jinyu Xiao et al. · IEEE Power and Energy Magazine · 2006 · 143 citations

Power Engineering, Engineering, Measurement +16

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer et al. · The Lancet Neurology · 2021 · 108 citations

Neurodegenerative Diseases, Neuropsychology, Alzheimer's Disease +11

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

Reza Khosravan, Brian Grabowski, Jingtao Wu et al. · Clinical Pharmacokinetics · 2006 · 104 citations

Healthy Subjects, Pharmacological Study, Pharmacology +6